69 related articles for article (PubMed ID: 2467343)
1. Determination of biologically active region in toxic shock syndrome toxin 1.
Kokan-Moore NP; Bergdoll MS
Rev Infect Dis; 1989; 11 Suppl 1():S125-9. PubMed ID: 2467343
[TBL] [Abstract][Full Text] [Related]
2. Localization of biologic functions of toxic shock syndrome toxin-1 by use of monoclonal antibodies and cyanogen bromide-generated toxin fragments.
Blomster-Hautamaa DA; Novick RP; Schlievert PM
J Immunol; 1986 Dec; 137(11):3572-6. PubMed ID: 3782792
[TBL] [Abstract][Full Text] [Related]
3. Identification of functional antigenic segments of toxic shock syndrome toxin 1 by differential immunoreactivity and by differential mitogenic responses of human peripheral blood mononuclear cells, using active toxin fragments.
Edwin C; Kass EH
Infect Immun; 1989 Jul; 57(7):2230-6. PubMed ID: 2731989
[TBL] [Abstract][Full Text] [Related]
4. Localization of a biologically important epitope on toxic-shock-syndrome toxin-1.
Murphy BG; Kreiswirth BN; Novick RP; Schlievert PM
J Infect Dis; 1988 Sep; 158(3):549-55. PubMed ID: 2457635
[TBL] [Abstract][Full Text] [Related]
5. Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody.
Blanco L; Choi EM; Connolly K; Thompson MR; Bonventre PF
Infect Immun; 1990 Sep; 58(9):3020-8. PubMed ID: 1696937
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
Bonventre PF; Heeg H; Cullen C; Lian CJ
Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of toxic-shock-syndrome toxin-1: derivation and characterization of immunologically and biologically active fragments.
Edwin C; Parsonnet J; Kass EH
J Infect Dis; 1988 Dec; 158(6):1287-95. PubMed ID: 3198939
[TBL] [Abstract][Full Text] [Related]
8. Effect of chemical modification of histidine and tyrosine residues in toxic shock syndrome toxin 1 on the serologic and mitogenic activities of the toxin.
Kokan-Moore NP; Bergdoll MS
Infect Immun; 1989 Jul; 57(7):1901-5. PubMed ID: 2499540
[TBL] [Abstract][Full Text] [Related]
9. Activation of in vitro proliferation of human T cells by a synthetic peptide of toxic shock syndrome toxin 1.
Edwin C; Swack JA; Williams K; Bonventre PF; Kass EH
J Infect Dis; 1991 Mar; 163(3):524-9. PubMed ID: 1995725
[TBL] [Abstract][Full Text] [Related]
10. Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1.
Murray DL; Prasad GS; Earhart CA; Leonard BA; Kreiswirth BN; Novick RP; Ohlendorf DH; Schlievert PM
J Immunol; 1994 Jan; 152(1):87-95. PubMed ID: 8254210
[TBL] [Abstract][Full Text] [Related]
11. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
Kum WW; Laupland KB; Chow AW
Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
Kum WW; Chow AW
J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
[TBL] [Abstract][Full Text] [Related]
13. The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1.
Blomster-Hautamaa DA; Kreiswirth BN; Kornblum JS; Novick RP; Schlievert PM
J Biol Chem; 1986 Nov; 261(33):15783-6. PubMed ID: 3782090
[TBL] [Abstract][Full Text] [Related]
14. Localisation of the mitogenic epitope of staphylococcal enterotoxin B.
Binek M; Newcomb JR; Rogers CM; Rogers TJ
J Med Microbiol; 1992 Mar; 36(3):156-63. PubMed ID: 1372360
[TBL] [Abstract][Full Text] [Related]
15. Toxic shock syndrome--the role of the toxin.
Bergdoll MS; Reiser RF; Crass BA; Robbins RN; Thompson NE
Postgrad Med J; 1985; 61 Suppl 1():35-8. PubMed ID: 3932991
[TBL] [Abstract][Full Text] [Related]
16. Detection of staphylococcal enterotoxin and toxic shock syndrome toxin-1 (TSST-1) by immunoblot combined with a semiautomated electrophoresis system.
Orden JA; Goyache J; Hernández FJ; Doménech A; Suárez G; Gómez-Lucía E
J Immunol Methods; 1991 Nov; 144(2):197-202. PubMed ID: 1960416
[TBL] [Abstract][Full Text] [Related]
17. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
[TBL] [Abstract][Full Text] [Related]
18. Structure-function analysis of toxic shock syndrome toxin 1.
Edwin C
Rev Infect Dis; 1989; 11 Suppl 1():S137-9. PubMed ID: 2928629
[No Abstract] [Full Text] [Related]
19. Specific immuno capturing of the staphylococcal superantigen toxic-shock syndrome toxin-1 in plasma.
Adams H; Brummelhuis W; Maassen B; van Egmond N; El Khattabi M; Detmers F; Hermans P; Braam B; Stam J; Verrips T
Biotechnol Bioeng; 2009 Sep; 104(1):143-51. PubMed ID: 19475676
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo.
Bonventre PF; Thompson MR; Adinolfi LE; Gillis ZA; Parsonnet J
Infect Immun; 1988 Jan; 56(1):135-41. PubMed ID: 3257201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
